Bladder Cancer | Norton Healthcare

Indication: Bladder Cancer

A Phase Ib/II Open Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Locally Advanced Or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy (MORPHEUS-mUC)

Sub-indication: Genitourinary Cancer

Study Type: Drug Study

Principal Investigator: Chandler Park, M.D.
Norton Cancer Institute

Sponsor: Sponsor: F. Hoffmann-LaRoche Ltd.

Learn more at

Email for more information:

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.